Sunday, February 2, 2025
HomeIndustriesBiotechnology

Biotechnology

China SXT Pharmaceuticals, Inc. Adds Newly Developed Kuihuapan and Zhudanfen Advanced TCMP Products

China SXT Pharmaceuticals, Inc. ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional...

AcelRx Pharma Highlights Advantages of the Sufentanil Sublingual Tablet in Joint Replacement Surgery

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced...

Mitsubishi Tanabe Pharma America Announces FDA Acceptance of New Drug Application (NDA) for Oral Edaravone Formulation for the Treatment of ALS

Mitsubishi Tanabe Pharma America, Inc. (MTPA) announced the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for an investigational...

RedHill Biopharma’s Oral Opaganib Significantly Improves Viral Clearance in Phase 2/3 Study in Severely Ill Hospitalized COVID-19 Patients

RedHill Biopharma Ltd.("RedHill" or the "Company"), a specialty biopharmaceutical company, announced new data from a prespecified analysis of all oral opaganib's Phase 2/3 study...

Bold Therapeutics Extends South Korea Option Agreement for BOLD-100, a First-in-Class Anti-Resistance Therapeutic

Bold Therapeutics, a clinical-stage biopharmaceutical company developing BOLD-100, is pleased to announce an extension of the option agreement with an undisclosed publicly traded South...
0FansLike
0FollowersFollow
spot_img

Hot Topics